Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Teng-Teng Chung"'
Autor:
Scott Akker, Sarah Pitkin, Mona Waterhouse, Matthew Matson, Teng-Teng Chung, Wing-Chiu Sze, Maralyn Druce, Anju Sahdev, Sam O’Toole, Anne Dawnay, Laila Parvanta, William Drake
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:e3776-e3784
Context In primary aldosteronism, cosecretion of cortisol may alter cortisol-derived adrenal venous sampling indices. Objective To identify whether cortisol cosecretion in primary aldosteronism alters adrenal venous sampling parameters and interpreta
Autor:
Anand Velusamy, Angela F. Brady, Joseph Carlow, Huw Dorkins, Rebecca Igbokwe, Benjamin Whitelaw, Teng-Teng Chung, Rachel Harrison, Fiona Lalloo, Paul Brennan, Louise Izatt, Schaida Schirwani, Alan Kelsall, Barbara McGowan, Sophie T Williams, Rosemarie Davidson, Paul V. Carroll, Nicola Tufton, Patrick J. Morrison, Soo-Mi Park, Christopher Bowles, John Newell-Price, Julian Adlard, Monika Kosicka-Slawinska, Eamonn R. Maher, Richard M. Martin, Lara Hawkes, Rebecca Dyer, Scott Akker, Rupert Obholzer, Florian Wernig, Tricia Tan, Ruth T Casey, Prodromos Chatzikyriakou, Gemma White, Anna L. Mitchell, Mary Porteous
Publikováno v:
Clinical endocrinologyREFERENCES. 96(4)
Objective Phaeochromocytomas and paragangliomas (PPGL) are rare, but strongly heritable tumours. Variants in succinate dehydrogenase (SDH) subunits are identified in approximately 25% of cases. However, clinical and genetic information of patients wi
Publikováno v:
Clinical Endocrinology. 71:86-91
Summary Aims To evaluate the long-term efficacy and safety of pegvisomant as a treatment for acromegaly. Design Retrospective analysis of clinical and trial data from all patients treated with pegvisomant since 1997 at two centres with common protoco
Publikováno v:
Clinical endocrinology. 84(4)
BACKGROUND Patients taking hydrocortisone (HC) replacement for primary or secondary adrenal failure require individual adjustment of their dose. In addition to modifying the administered doses of HC for each patient, physicians are increasingly inter
Autor:
John P. Monson, G. M. Besser, Ashley B. Grossman, D. M. Walker, Jane Evanson, W. M. Drake, Scott Akker, Teng-Teng Chung
Publikováno v:
Clinical endocrinology. 68(6)
Summary Background Published data suggest that growth hormone replacement (GHR) may be given safely to patients with hypopituitarism consequent upon a pituitary/peripituitary tumour. However, a preponderance of patients treated with external pituitar
Autor:
Jane Evanson, Teng-Teng Chung, W. M. Drake, G. M. Besser, S. L. Chew, Ashley B. Grossman, D. M. Walker, John P. Monson, Piers N. Plowman
Publikováno v:
Clinical endocrinology. 63(3)
Summary Objective GH replacement is widely used in the management of patients with adult-onset (AO)-GH deficiency (GHD). In most cases, AO-GHD arises as a result of pituitary/peripituitary tumours and/or their treatment, but the effect of GH replacem